DATA MEDICAL SERVICE S.R.L
FREEQC VEQ Marcatori
Tumorali - Periodo 01/2019 -
Esercizio Statistico 01
Page # 1-
rilasciato il 26/02/2019 . Risposte pervenute : 146
Parametri |
Valore Medio TUTTI i Metodi |
Dev.
Std. |
CV
% |
|||
|
01A |
01B |
01A |
01B |
01A |
01B |
030 CEA ng/ml |
49.87 |
19.09 |
0.53 |
0.55 |
1.06 |
2.88 |
031 AFP ng/ml |
236.50 |
85.52 |
0.55 |
0.53 |
0.23 |
0.61 |
032 Ca 19-9
UI/ml |
310.54 |
126.49 |
0.54 |
0.52 |
0.17 |
0.41 |
033 Ca 125 UI/ml |
165.42 |
74.43 |
0.70 |
0.28 |
0.42 |
0.37 |
034 Ca 15.3
UI/ml |
105.98 |
45.62 |
0.49 |
0.55 |
0.46 |
1.20 |
036 B2MG mg/ml |
0.64 |
0.35 |
0.03 |
0.03 |
4.68 |
8.57 |
037 HCG mUI/ml |
30.45 |
5.36 |
1.71 |
1.02 |
5.61 |
19.02 |
038 PSA mg/ml |
24.26 |
4.77 |
0.37 |
0.21 |
1.52 |
4.40 |
039 PSA
libero mg/ml |
15.12 |
2.87 |
0.21 |
0.05 |
1.38 |
1.74 |
FREEQC VEQ Marcatori
Tumorali - Periodo 02/2019 -
Esercizio Statistico 02
Page # 1-
rilasciato il 26/03/2019 . Risposte pervenute : 146
Parametri |
Valore Medio TUTTI i Metodi |
Dev.
Std. |
CV
% |
|||
|
02
A |
02
B |
02
A |
02
B |
02
A |
02
B |
030 CEA ng/ml |
2.44 |
57.78 |
0.06 |
0.60 |
2.45 |
1.03 |
031 AFP ng/ml |
8.04 |
206.31 |
0.06 |
5.47 |
0.74 |
2.65 |
032 Ca 19-9
UI/ml |
51.69 |
725.08 |
0.49 |
5.79 |
0.94 |
0.79 |
033 Ca 125 UI/ml |
30.84 |
137.41 |
2.56 |
3.62 |
8.30 |
2.63 |
034 Ca 15.3
UI/ml |
17.85 |
153.97 |
0.47 |
2.20 |
2.63 |
1.42 |
036 B2MG mg/ml |
0.22 |
0.23 |
0.03 |
0.02 |
13.63 |
8.69 |
037 HCG mUI/ml |
32.67 |
95.10 |
1.08 |
2.79 |
3.30 |
2.93 |
038 PSA mg/ml |
0.62 |
16.56 |
0.02 |
0.05 |
3.22 |
0.30 |
039 PSA
libero mg/ml |
0.36 |
11.63 |
0.05 |
0.08 |
13.88 |
0.68 |
DATA MEDICAL SERVICE S.R.L
FREEQC VEQ Marcatori
Tumorali - Periodo 03/2019 -
Esercizio Statistico 03
Page # 1-
rilasciato il 12/04/2019 . Risposte pervenute : 146
Parametri |
Valore Medio TUTTI i Metodi |
Dev.
Std. |
CV
% |
|||
|
03
A |
03
B |
03
A |
03
B |
03
A |
03
B |
030 CEA ng/ml |
0.56 |
39.68 |
0.05 |
0.31 |
8.92 |
0.78 |
031 AFP ng/ml |
1.59 |
191.61 |
0.25 |
0.29 |
15.72 |
0.15 |
032 Ca 19-9
UI/ml |
36.90 |
287.12 |
0.53 |
4.62 |
1.43 |
1.60 |
033 Ca 125 UI/ml |
21.33 |
146.16 |
1.59 |
2.19 |
7.45 |
1.49 |
034 Ca 15.3
UI/ml |
8.57 |
90.87 |
0.24 |
0.50 |
2.80 |
0.55 |
036 B2MG mg/ml |
0.22 |
0.22 |
0.03 |
0.03 |
13.63 |
13.63 |
037 HCG mUI/ml |
32.67 |
95.10 |
1.08 |
2.79 |
3.30 |
2.93 |
038 PSA mg/ml |
0.27 |
20.38 |
0.04 |
0.24 |
14.81 |
1.17 |
039 PSA
libero mg/ml |
0.23 |
12.16 |
0.02 |
0.04 |
8.69 |
0.32 |
FREEQC VEQ Marcatori
Tumorali - Periodo 04/2019 -
Esercizio Statistico 04
Page # 1-
rilasciato il 06/05/2019 . Risposte pervenute : 146
Parametri |
Valore Medio TUTTI i Metodi |
Dev.
Std. |
CV
% |
|||
|
04
A |
04
B |
04
A |
04
B |
04
A |
04
B |
030 CEA ng/ml |
49.87 |
19.09 |
0.53 |
0.55 |
1.06 |
2.88 |
031 AFP ng/ml |
236.50 |
85.52 |
0.55 |
0.53 |
0.23 |
0.61 |
032 Ca 19-9
UI/ml |
310.54 |
126.49 |
0.54 |
0.52 |
0.17 |
0.41 |
033 Ca 125 UI/ml |
165.42 |
74.43 |
0.70 |
0.28 |
0.42 |
0.37 |
034 Ca 15.3
UI/ml |
105.98 |
45.62 |
0.49 |
0.55 |
0.46 |
1.20 |
036 B2MG mg/ml |
0.64 |
0.35 |
0.03 |
0.03 |
4.68 |
8.57 |
037 HCG mUI/ml |
30.45 |
5.36 |
1.71 |
1.02 |
5.61 |
19.02 |
038 PSA mg/ml |
24.26 |
4.77 |
0.37 |
0.21 |
1.52 |
4.40 |
039 PSA libero
mg/ml |
15.12 |
2.87 |
0.21 |
0.05 |
1.38 |
1.74 |
DATA MEDICAL SERVICE S.R.L
FREEQC VEQ Marcatori
Tumorali - Periodo 05/2019 -
Esercizio Statistico 05
Page # 1-
rilasciato il 12/06/2019 . Risposte pervenute : 146
Parametri |
Valore Medio TUTTI i Metodi |
Dev.
Std. |
CV
% |
|||
|
05
A |
05
B |
05
A |
05
B |
05
A |
05
B |
030 CEA ng/ml |
21.88 |
1.37 |
0.53 |
0.08 |
2.42 |
5.83 |
031 AFP ng/ml |
89.47 |
7.01 |
0.64 |
0.05 |
0.71 |
0.71 |
032 Ca 19-9
UI/ml |
324.54 |
50.39 |
5.41 |
0.54 |
1.66 |
1.07 |
033 Ca 125 UI/ml |
65.36 |
28.54 |
25.29 |
0.32 |
38.69 |
1.12 |
034 Ca 15.3
UI/ml |
73.94 |
15.62 |
2.17 |
0.27 |
2.93 |
1.72 |
036 B2MG mg/ml |
1.56 |
0.22 |
0.06 |
0.03 |
3.84 |
13.63 |
037 HCG mUI/ml |
30.45 |
5.36 |
1.71 |
1.02 |
5.61 |
19.02 |
038 PSA mg/ml |
8.17 |
0.53 |
0.09 |
0.03 |
1.10 |
5.66 |
039 PSA libero
mg/ml |
4.86 |
0.33 |
0.05 |
0.03 |
1.02 |
9.09 |